152 related articles for article (PubMed ID: 23534732)
1. Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups.
Utkan G; Ürün Y; Cangir AK; Kılıç D; Özdemir NY; Oztuna DG; Bulut E; Arslan ÜY; Koçer M; Kavukçu Ş; İçli F
Asian Pac J Cancer Prev; 2013; 14(1):249-53. PubMed ID: 23534732
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
4. Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study.
Mutlu H; Gündüz S; Karaca H; Büyükçelik A; Cihan YB; Erden A; Akca Z; Coşkun HS
Med Oncol; 2014 Aug; 31(8):74. PubMed ID: 24958517
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
Habib EE; Fahmy ES
Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
Kim ST; Park JY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
Jpn J Clin Oncol; 2010 Nov; 40(11):1031-6. PubMed ID: 20534685
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Simon GR; Verschraegen CF; Jänne PA; Langer CJ; Dowlati A; Gadgeel SM; Kelly K; Kalemkerian GP; Traynor AM; Peng G; Gill J; Obasaju CK; Kindler HL
J Clin Oncol; 2008 Jul; 26(21):3567-72. PubMed ID: 18640937
[TBL] [Abstract][Full Text] [Related]
9. Novel combinations using pemetrexed in malignant mesothelioma.
Gadgeel SM; Pass HI
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S61-6. PubMed ID: 15117427
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and gemcitabine in malignant mesothelioma.
Nowak AK; Byrne MJ
Ann Oncol; 2005 Oct; 16(10):1711. PubMed ID: 16000339
[No Abstract] [Full Text] [Related]
11. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group.
Ürün Y; Utkan G; Yalcin Ş; Coşkun HŞ; Koçer M; Özdemir NY; Kaplan MA; Arslan ÜY; Özdemir F; Öztuna D; Akbulut H; İçli F
Asian Pac J Cancer Prev; 2012; 13(8):4129-31. PubMed ID: 23098529
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H
J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397
[TBL] [Abstract][Full Text] [Related]
13. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
[TBL] [Abstract][Full Text] [Related]
14. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
[TBL] [Abstract][Full Text] [Related]
15. Emerging insights into the biology and therapy of malignant mesothelioma.
Vogelzang NJ
Semin Oncol; 2002 Dec; 29(6 Suppl 18):35-42. PubMed ID: 12571809
[TBL] [Abstract][Full Text] [Related]
16. [Malignant pleural mesothelioma].
Nishiwaki Y
Gan To Kagaku Ryoho; 2003 May; 30(5):589-94. PubMed ID: 12795087
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
18. [Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].
Margery J; Rivière F; Planchard D; Le Floch H; Ferrand FR; Mairovitz A; Besse B; Vaylet F; Ruffié P
Rev Pneumol Clin; 2010 Sep; 66(4):255-9. PubMed ID: 20933167
[TBL] [Abstract][Full Text] [Related]
19. Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
Zucali PA; Simonelli M; Michetti G; Tiseo M; Ceresoli GL; Collovà E; Follador A; Lo Dico M; Moretti A; De Vincenzo F; Lorenzi E; Perrino M; Giordano L; Farina G; Santoro A; Garassino M
Lung Cancer; 2012 Mar; 75(3):360-7. PubMed ID: 21937142
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
Krug LM; Wozniak AJ; Kindler HL; Feld R; Koczywas M; Morero JL; Rodriguez CP; Ross HJ; Bauman JE; Orlov SV; Ruckdeschel JC; Mita AC; Fein L; He X; Hall R; Kawabe T; Sharma S
Lung Cancer; 2014 Sep; 85(3):429-34. PubMed ID: 25047675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]